Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) vs ProCap Acquisition Corp (PCAP)
A side-by-side comparison of Drugs Made In America Acquisition Corp. Ordinary Shares and ProCap Acquisition Corp across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
$10.89Financial ServicesDelayed quote: Oct 6, 2026, 10:56 AM EDT
PCAP
ProCap Acquisition Corp
$10.40Financial ServicesDelayed quote: Oct 6, 2026, 10:27 AM EDT
Total return — DMAA vs PCAP
growth of $100 · dividends reinvested · last 1yDMAA +7.6% (+7.6%/yr)PCAP -2.8% (-2.8%/yr)DMAA compounded faster over this window
DMAA PCAP
DMAA vs PCAP: by the numbers
- •PCAP is the larger company ($264M vs $264M market cap).
- •PCAP trades at the lower trailing earnings multiple (31.55 vs 55.48 P/E), one valuation lens rather than an overall verdict.
Metrics side by side
Valuation
| Metric | DMAA | PCAP |
|---|---|---|
| P/E ratio | 55.48 | 31.55 |
| P/B ratio | 1.92 | 1.06 |
Profitability
| Metric | DMAA | PCAP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 4.42% | 3.49% |
| ROIC | -1.82% | -0.23% |
Frequently asked
- Which has the lower trailing P/E, DMAA or PCAP?
- PCAP has the lower trailing P/E: DMAA trades at 55.48 and PCAP at 31.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Go deeper
Dig into the metrics
Drugs Made In America Acquisition Corp. Ordinary Shares P/E ratioProCap Acquisition P/E ratioDrugs Made In America Acquisition Corp. Ordinary Shares ROEProCap Acquisition ROEDrugs Made In America Acquisition Corp. Ordinary Shares operating marginProCap Acquisition operating marginDrugs Made In America Acquisition Corp. Ordinary Shares revenue growthProCap Acquisition revenue growthDrugs Made In America Acquisition Corp. Ordinary Shares free cash flowProCap Acquisition free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.